MoneyWorks4Me

Lupin - Quaterly Results

06 Aug 2024 Evaluate
A fair growth of 19.22% in the revenue at Rs. 41676.30 millions was reported in the June 2024 quarter as compared to Rs. 34956.40 millions during year-ago period.Net profit surges 86.43% to Rs. 8891.80  millions  from Rs. 4769.60 millions in the quarter ended June 2024.Operating profit for the quarter ended June 2024 rose to 12378.90 millions as compared to 7327.60 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 41676.30 34956.40 19.22 41676.30 34956.40 19.22 146665.00 112588.30 30.27
Other Income 390.80 277.40 40.88 390.80 277.40 40.88 1067.30 912.60 16.95
PBIDT 12378.90 7327.60 68.94 12378.90 7327.60 68.94 35657.90 11739.20 203.75
Interest 135.50 161.80 -16.25 135.50 161.80 -16.25 563.50 984.40 -42.76
PBDT 12243.40 7165.80 70.86 12243.40 7165.80 70.86 35094.40 10754.80 226.31
Depreciation 1414.20 1400.50 0.98 1414.20 1400.50 0.98 7247.50 5483.40 32.17
PBT 10829.20 5765.30 87.83 10829.20 5765.30 87.83 27846.90 5271.40 428.26
TAX 1937.40 995.70 94.58 1937.40 995.70 94.58 4586.00 1019.30 349.92
Deferred Tax 45.50 -11.50 -495.65 45.50 -11.50 -495.65 -254.50 60.40 -521.36
PAT 8891.80 4769.60 86.43 8891.80 4769.60 86.43 23260.90 4252.10 447.04
Equity 911.90 910.20 0.19 911.90 910.20 0.19 911.40 910.00 0.15
PBIDTM(%) 29.70 20.96 41.70 29.70 20.96 41.70 24.31 10.43 133.18
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..